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INSTRUCTIONS TO AUTHORS
The Journal of Orthopaedic Translation (JOT) is the 
official peer-reviewed publication of the Chinese 
Speaking Orthopaedic Society (CSOS) and the 
International Chinese Musculoskeletal Research Society 
(ICMRS). It is published quarterly by Elsevier in January, 
April, July and October, and is indexed in ScienceDirect.
The Journal accepts articles on translation medicine 
in musculoskeletal and related themes that will identify 
and fill scientific knowledge gaps at the junction of 
basic research and clinical application. Authors are 
welcome to submit original articles, review articles, 
editorials, perspectives and letters to the editor for 
consideration.
The Editorial Board requires authors to be in 
compliance with the Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals (URMs), 
which are compiled by the International Committee of 
Medical Journal Editors (ICMJE); current URMs are 
available at www.icmje.org.
These Instructions to Authors are revised periodically 
by the Editors as needed. Authors should consult a 
recent issue of the Journal or visit www.e-jot.com for 
the latest version of these instructions. Any manuscript 
not prepared according to these instructions will be 
returned immediately to the author(s) without review.
1. Manuscript Submission
1.1. Online Submission
Manuscripts (meaning all submission items, including all 
text, tables, artwork, cover letter, conflicts of interest 
disclosures, and any other required documents/
material) must be submitted online to the JOT through 
the Elsevier Editorial System (EES) at http://ees.
elsevier.com/jot. If assistance is required, please refer 
to the tutorials for authors and/or customer support 
that are available on the EES website; you may also 
contact the Editorial Office. Please do not post, fax or 
e-mail your manuscripts to the Editorial Office.
Editorial Office
Journal of Orthopaedic Translation (JOT)
Department of Orthopaedics & Traumatology
The Chinese University of Hong Kong
Room 74029, 5/F, Clinical Sciences Building
Prince of Wales Hospital, Shatin, New Territories
Hong Kong SAR
Tel: (+852) 2632-2083
Fax: (+852) 2646-3020
E-mail: joteditorial@ort.cuhk.edu.hk
1.2. Important Information
•	 Articles	 should	 be	 in	 Microsoft	 Word	 document	
format and prepared in the simplest form possible. 
We will add in the correct font, font size, margins 
and so on according to the Journal’s style.
•	 You	may	use	automatic	page	numbering,	but	do	NOT	
use other kinds of automatic formatting such as 
footnotes, headers and footers. References 
especially should NOT be formatted using the MS 
Word “endnotes” or “footnotes” function; instead, 
you may use the commercially available EndNote® 
or Reference Manager® software to manage your 
references.
•	 Put	text,	references,	table	headings	and	tables,	and	
figure legends in one file.
•	 Figures	must	be	submitted	as	separate	picture	files,	
at the correct resolution and named according to 
the figure number and format, e.g., “Fig1.tif”, 
“Fig2.jpg”. Please see section 9.8. for more 
information.
1.3. Supporting Documents
The following documents must be included in your 
submission (refer also to the Checklist that follows 
these author instructions). Items (1), (2) and (3) are 
mandatory. Items (4), (5), (6) and (7) are required only 
if they are applicable to your manuscript.
(1) Cover Letter. This must include the following 
information: 
•	 title	of	the	manuscript
•	 names	(spelled	out	in	full)	of	all	the	authors*,	and	
the institutions with which they are affiliated; 
indicate all affiliations with a superscripted 
lowercase letter after the author’s name and in 
front of the matching affiliation (*the name of each 
author should be written with the family name last, 
e.g., Yuen-Lam Cheung)
•	 corresponding	author	details	(name,	e-mail,	mailing	
address, telephone and fax numbers)
•	 a	 statement	 that	 the	 material	 contained	 in	 the	
manuscript has not been previously published and is 
not being concurrently submitted elsewhere
•	 persons	who	 do	 not	 fulfill	 the	 requirements	 to	 be	
listed as authors but who nevertheless contributed 
to the manuscript (such as those who provided 
writing assistance, for example) should be disclosed
•	 list	 of	 manuscripts	 that	 have	 been	 published,	
submitted, or are in press that are similar to the 
submission to the JOT (and include in your 
submission copies of those similar manuscripts so 
that JOT  Editors can be assured there is no overlap)
•	 the	signature	of	the	corresponding	author
•	 Optional: if you have a list of reviewers who you 
wish to review or not to review your manuscript, 
you may include this list in the cover letter
(2) Authorship & Conflicts of Interest Statement. Each 
author’s contribution to the manuscript should be 
listed. Any and all potential and actual conflicts of 
interest should also be listed (see Section 2 for more 
information). Please use the JOT Authorship & 
Conflicts of Interest Statement form that follows 
these author instructions and that is also provided 
on	 the	 Journal’s	 website	 at	 www.e-jot.com.	 Your	
signature and those of ALL your coauthors must be 
included.
(3) Copyright Transfer Agreement. In the event that your 
manuscript is accepted for publication in the JOT, you 
are required to transfer all copyright ownership in and 
relating to the work to the Chinese Speaking 
Orthopaedic Society (CSOS). Please use the JOT 
Copyright Transfer Agreement form that follows these 
author instructions and that is also provided on the 
Journal’s	 website	 at	 www.e-jot.com.	 Your	 signature	
and those of ALL your coauthors must be included.
(4) Ethics Statement. Articles covering the use of human 
or animal samples in research, or human or animal 
experiments must be accompanied by a letter of 
approval from the relevant review committee or 
authorities. See Section 3 for more information.
(5) Consolidated Standards of Reporting Trials 
(CONSORT) flow chart for randomized controlled 
trials submitted for publication. See Section 4 for 
more information.
(6) Signed Statement of Informed Consent. Articles 
where human subjects can be identified in 
descriptions, photographs or pedigrees must be 
accompanied by a signed statement of informed 
consent to publish (in print and online) the 
descriptions, photographs and pedigrees from each 
subject who can be identified. See Section 5 for 
more information.
(7) Copyright Permission. If you have reproduced or 
adapted material from other copyrighted sources, 
the letter(s) of permission from the copyright 
holder(s) to reproduce or adapt the copyrighted 
sources must be supplied. Otherwise, such material 
must be removed from your manuscript.
2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s 
objectivity is potentially compromised by a desire for 
financial gain, prominence, professional advancement 
or a successful outcome. JOT Editors strive to ensure 
that what is published in the Journal is as balanced, 
objective and evidence-based as possible. Since it can 
be difficult to distinguish between an actual conflict of 
interest and a perceived conflict of interest, the Journal 
requires authors to disclose all and any potential 
conflicts of interest.
Conflicts of interest may be financial or non-financial. 
Financial conflicts include financial relationships such as 
honoraria; educational grants; participation in speakers’ 
bureaus; membership, employment, consultancies, 
stock ownership, or other equity interest; expert 
testimony or patent-licensing arrangements. Non-
financial conflicts include personal or professional 
relationships, affiliations, academic competition, 
intellectual passion, knowledge or beliefs that might 
affect objectivity.
Please ensure that the name of each author listed in 
your manuscript appears in either Section I or Section II 
on page 2 of the JOT Authorship & Conflicts of Interest 
Statement form (an author’s name cannot appear in 
both Section I and Section II of the form).
3.  Ethical Approval of Studies and Informed 
Consent
For human or animal experimental investigations, 
appropriate institutional review board or ethics 
committee approval is required, and such approval 
should be stated in the methods section of the 
manuscript. For those investigators who do not have 
formal ethics review committees, the principles outlined 
in the Declaration of Helsinki should be followed (World 
Medical Association. Declaration of Helsinki: ethical 
principles for medical research involving human 
subjects. Available at: www.wma.net/en/30publications 
/10policies/b3/17c.pdf).
For investigation of human subjects, state explicitly in 
the methods section of the manuscript that informed 
consent was obtained from all participating adult subjects 
and from parents or legal guardians for minors or 
incapacitated adults, together with the manner in which 
informed consent was obtained (e.g., oral or written).
For work involving animals, the guidelines for their 
care and use that were followed should be stated in the 
methods section of the manuscript. For those investigators 
who do not have formal institutional guidelines relating 
to animal experiments, the European Commission 
Directive 86/609/EEC for animal experiments (available 
at http://ec.europa.eu/environment/chemicals/lab_
animals/legislation_en.htm) should be followed and the 
same should be stated in the methods section of the 
manuscript.
4. Reporting Clinical Trials
All randomized controlled trials submitted for publication 
should include a completed Consolidated Standards of 
Reporting Trials (CONSORT) flow chart (please go to www.
consort-statement.org for more information). The JOT 
has adopted the ICMJE proposal that requires, as a 
condition of consideration for publication of clinical 
trials, registration in a public trials registry. Purely 
observational studies (those in which the assignment of 
the medical intervention is not at the discretion of the 
investigator) will not require registration. Further 
information can be found at www.icmje.org.
5.  Identification of Patients in Descriptions, 
Photographs and Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs and 
pedigrees should be obtained from all persons (parents 
or legal guardians for minors) who can be identified 
(including by the patients themselves) in such written 
descriptions, photographs or pedigrees. Such persons 
should be shown the manuscript before its submission. 
Omitting data or making data less specific to de-identify 
patients is acceptable, but changing any such data is not 
acceptable. State explicitly in the methods section of 
the manuscript that informed consent was obtained 
from all participating adult subjects or from parents or 
legal guardians for minors or incapacitated adults, 
together with the manner in which informed consent 
was obtained (i.e., oral or written).
6.  Previous Publication or Duplicate 
Submission
Submitted manuscripts are considered with the 
understanding that they have not been published 
previously in print or electronic format (except in 
abstract or poster form) and are not under consideration 
in totality or in part by another publication or electronic 
medium.
7. Basic Criteria
Articles should be written in English, using British English 
spelling, and meet the following basic criteria: the 
material is original, the information is important, the 
writing is clear and concise, the study methods are 
appropriate, the data are valid, and the conclusions are 
reasonable and supported by the data.
8. Article Categories
The categories of articles that are published in the 
Journal are listed and described below. Please select 
the category that best describes your paper. If your 
paper does not fall into any of these categories, please 
contact the Editorial Office.
8.1. Original Articles
These articles typically include randomized trials, 
intervention studies, studies of screening and diagnostic 
tests, laboratory and animal studies, cohort studies, 
cost-effectiveness analyses, case-control studies, and 
surveys with high response rates, which represent new 
and significant contributions to translational research in 
the field of orthopaedics. They should include an 
abstract and be structured as follows: Abstract, 
Introduction, Materials and Methods, Results, Discussion, 
Conflicts of Interest Statement, Acknowledgements 
(if any), References, Figures and Tables (if any), and 
Supplementary Material (if any).
The Introduction should provide a brief background 
to the subject of the paper, explain the importance of 
the study, and state a precise study question or purpose.
The Materials and Methods section should describe 
the study design and methods (including the study 
setting and dates, patients/participants with inclusion 
and exclusion criteria, patient samples or animal 
specimens used, the essential features of any 
interventions, the main outcome measures, the 
laboratory methods followed, or data sources and how 
these were selected for the study), and state the 
statistical procedures employed in the research.
The Results section should comprise the study results 
presented in a logical sequence, supplemented by tables 
and/or figures. Take care that the text does not repeat 
data that are presented in tables and/or figures. Only 
emphasize and summarize the essential features of the 
main results.
The Discussion section should be used to emphasize 
the new and important aspects of the study, placing the 
results in context with published literature, the 
implications of the findings, and the conclusions that 
follow from the study results.
The text should be limited to 6000 words in length 
with not more than 8 figures/tables and 40 references. 
The Journal does not accept original articles of case 
reports and case series.
8.2. Review Articles
These should provide a balanced synthesis of current 
knowledge on translational research in musculoskeletal 
and related themes. These articles have the specific 
goal of identifying challenges and bottlenecks that are 
preventing translation of biomedical research advances 
for a particular disease or clinical disorder into new 
treatments for patients, with constructive suggestions 
for ways to overcome these challenges.
Reviews can be up to 6000 words in length. They should 
have a short pithy title, an abstract of not more than 100 
words, not more than 80 references and up to 4 figures/
tables. While reviews are usually submitted by invitation 
only, unsolicited reviews will also be given due consideration.
8.3. Editorials
Editorials are short and invited opinion(s) that discuss an 
issue of immediate importance to the translational 
orthopaedic community. These are usually written by 
invited authors or editorial board members and are 
comments on recent news or articles published in the 
Journal. Editorials should be no longer than 1000 words 
with no more than 5 references. A photograph of the 
author(s) is required for illustration.
8.4. Perspectives
Perspectives discuss one or several papers recently pub-
lished in the JOT or other journals that present key findings 
in translational research relevant to musculoskeletal health 
and disorders. Perspectives should discuss the research from 
both a basic and clinical viewpoint and should describe the 
implications of the research for patient care.
Perspectives are limited to 4000 words (including 
abstract, main text, references and figure legends). 
They should have a concise title, an abstract of 50 words 
or less, no more than 35 references, and 1 or 2 figures 
(with figure legends) or tables.
8.5. Letters to the Editor
Letters provide readers with an opportunity to raise 
issues of interest to the translational medicine 
community or to respond to an article previously 
published in the JOT. Letters should provide new 
information or a fresh perspective on the previously 
published article.
Letters should be less than 1000 words, with not 
more than 10 references and 2 figures/tables. Letters 
are sent to the author(s) of the previously published 
article under discussion for their response.
9. Manuscript Preparation
Text should be typed double-spaced on white A4 (297 × 
210 mm) paper, with outer margins of 2.5 cm. The 
manuscript should include a title page, abstract, 
keywords, text, conflicts of interest statement, 
acknowledgements (if any), references, and figures and 
tables as appropriate. Each section of the manuscript 
should begin on a new page. Pages should be numbered 
consecutively, beginning with the title page.
9.1. Title Page
The title page should contain the following information 
(in order, from the top to bottom of the page):
•	 article	category
•	 article	title
•	 running	title	not	exceeding	50	characters
•	 IMPORTANT: please do NOT include any author names 
and affiliations or corresponding author information 
on the title page (this information should be listed in 
your cover letter instead) because the JOT follows a 
double-blind peer review process
9.2. Abstracts and Keywords
An unstructured abstract (i.e., in one single paragraph 
with no subheadings), of no more than 500 words in 
length, and 3—5 relevant keywords (in alphabetical 
order) are required for the following article categories: 
Original Articles, Review Articles and Perspectives. 
Keywords should be taken from the Medical Subject 
Headings (MeSH) list of Index Medicus (www.nlm.nih.
gov/mesh/meshhome.html).
No abstract or keywords are required for Editorials 
and Letters to the Editor.
9.3. Main Text
The text for Original Articles should be organized 
into the following sections: Introduction, Materials 
and Methods, Results, Discussion, Conflicts of 
Interest Statement, Acknowledgements (if any), and 
References. Each section should begin on a new 
page.
9.3.1. Abbreviations
Where a term/definition will be continually referred 
to, it must be written in full when it first appears in 
the text, followed by the subsequent abbreviation in 
parentheses. Thereafter, the abbreviation may be 
used. An abbreviation should not be first defined in 
any section heading; if an abbreviation has previously 
been defined in the text, then the abbreviation may 
be used in a subsequent section heading. Restrict the 
number of abbreviations to those that are absolutely 
necessary.
9.3.2. Numbers
Numbers that begin a sentence or those that are less 
than 10 should be spelled out using letters. Centuries 
and decades should be spelled out, e.g. the Eighties or 
nineteenth century. Laboratory parameters, time, 
temperature, length, area, mass, and volume should be 
expressed using digits.
9.3.3. Units
Système International (SI) units must be used, with the 
exception of blood pressure values which are to be 
reported in mmHg. Use the metric system for the 
expression of length, area, mass, and volume. 
Temperatures are to be given in degrees Celsius.
9.3.4. Names of drugs, devices and other products
Use the Recommended International Non-proprietary 
Name (rINN) for medicinal substances, unless the 
specific trade name of a drug is directly relevant to the 
discussion. Generic drug names should appear in 
lowercase letters in the text. If a specific proprietary 
drug needs to be identified, the brand name may appear 
only once in the manuscript in parentheses following the 
generic name the first time the drug is mentioned in the 
text.
For devices and other products, the specific brand or 
trade name, the manufacturer and their location (city, 
state, country) should be provided the first time the 
device or product is mentioned in the text, for example, 
“…SPSS version 11 was used (SPSS Inc., Chicago, IL, 
USA)”. Thereafter, the generic term (if appropriate) 
should be used.
9.3.5. Gene nomenclature
Current standard international nomenclature for genes 
should be adhered to. For human genes, use genetic 
notation and symbols approved by the HUGO Gene 
Nomenclature	 Committee	 (www.genenames.org).	 You	
may also refer to the resources available on PubMed at 
www.ncbi.nlm.nih.gov/guide/genes-expression. The 
Human Genome Variation Society has a useful site that 
provides guidance in naming mutations at www.hgvs.
org/mutnomen/index.html. In your manuscript, genes 
should be typed in italic font and include the accession 
number.
9.3.6. Statistical requirements
Statistical analysis is essential for all research papers. 
Use correct nomenclature for statistical methods 
(e.g., two sample t test, not unpaired t test). 
Descriptive statistics should follow the scales used in 
data description. Inferential statistics are important 
for interpreting results and should be described in 
detail.
All p values should be presented to the third decimal 
place for accuracy. The smallest p value that should be 
expressed is p < 0.001 since additional zeros do not 
convey useful information; the largest p value that 
should be expressed is p > 0.99.
9.3.7. Personal communications and unpublished data
These sources cannot be included in the references list 
but may be described in the text. The author(s) must 
give the full name and highest academic degree of the 
person, the date of the communication, and indicate 
whether it was in oral or written (letter, fax, e-mail) 
form. A signed statement of permission should be 
included from each person identified as a source of 
information in a personal communication or as a source 
for unpublished data.
9.4. Conflicts of Interest Statement and/or 
Funding/Support Statement
Since it is difficult to distinguish between an actual 
conflict of interest and a perceived conflict of interest, 
the JOT requires authors to disclose all and any potential 
conflicts of interest and let readers judge for themselves. 
Therefore, please ensure that you provide information 
about any potential financial and non-financial conflicts 
of interest (see Section 2 for more information) in a 
concise paragraph after the main text.
All financial and material support for the research, 
work, writing and editorial assistance from internal or 
external agencies, including commercial companies, 
should be clearly and completely identified in a Funding/
Support Statement.
9.4.1. Special note to reviewers
Reviewers form the cornerstone of the peer-review 
process, and their evaluations ensure the quality of 
published research. Therefore, the Editors seek 
reviewers for JOT who do not have conflicts of interest 
with the reported research in the manuscripts.
9.5. Acknowledgements
After the Conflicts of Interest Statement and/or 
Funding/Support Statement, general acknowledgements 
for consultations and statistical analyses should be listed 
concisely, including the names of the individuals who 
were directly involved. Consent should be obtained 
from those individuals before their names are listed in 
this section. Those acknowledged should not include 
secretarial, clerical or technical staff whose 
participation was limited to the performance of their 
normal duties.
9.6. References
Authors are responsible for the accuracy and 
completeness of their references and for correct in-text 
citation.
9.6.1. In the main text, tables and figure legends
•	 References	should	be	indicated	by	numbers	in	square	
brackets in line with the text, numbered consecutively 
in order of appearance, and placed before 
punctuation. [The actual authors can be referred to, 
but the reference number(s) must always be given.]
•	 References	cited	in	tables	or	figure	legends	should	be	
included in sequence at the point where the table or 
figure is first mentioned in the main text.
•	 Do	 not	 cite	 abstracts	 unless	 they	 are	 the	 only	
available reference to an important concept.
•	 Do	not	cite	uncompleted	work	or	work	that	has	not	
yet been accepted for publication (i.e., “unpublished 
observation”, “personal communication”) as references. 
Also see Section 9.3.7.
9.6.2. In the references list
•	 References	 should	 be	 compiled	 at	 the	 end	 of	 the	
manuscript according to the order of citation in the text.
•	 References	 should	 be	 limited	 to	 those	 cited	 in	 the	
text only.
•	 Journal	references	should	include,	in	order,	authors’	
surnames and initials, article title, abbreviated 
journal name, year, volume and inclusive page 
numbers.
•	 The	surnames	and	initials	of	all	the	authors	up	to	6	
should be included, but when authors number 7 or 
more, list the first 6 authors only followed by “et al”.
•	 Abbreviations	 for	 journal	 names	 should	 conform	 to	
those used in MEDLINE.
•	 If	citing	a	website,	provide	the	author	 information,	
article title, website address and the date you 
accessed the information.
•	 Reference	to	an	article	that	is	in	press	must	state	the	
journal name and, if possible, the year and volume.
Examples of the most common reference types are 
provided below. (Please pay particular attention to the 
formatting, word capitalization, spacing and style.)
Standard journal article
Niemansburg SL, van Delden JJ, Dhert WJ, Bredenoord 
AL. Regenerative medicine interventions for orthopedic 
disorders: ethical issues in the translation into patients. 
Regen Med 2013;8:65—73.
Journal supplement
Mashiba	T,	Mori	S,	Burr	DB,	Komatsubara	S,	Cao	Y,	Manabe	
T, et al. The effects of suppressed bone remodeling by 
bisphosphonates on microdamage accumulation and 
degree of mineralization in the cortical bone of dog rib. J 
Bone Miner Metab 2005;23 Suppl:36—42.
Journal article not in English but with English abstract
Zhang	L,	Li	ZY,	Liu	JS,	Sun	J,	Ma	J,	Zhang	S,	et	al.	Clinical	
results of anatomical reconstruction of the lateral 
ligaments for chronic ankle instability. Zhongguo Gu 
Shang 2012;25:886—90. [In Chinese, English abstract]
Book with edition
Hsu JD, Michael J, Fisk J. AAOS atlas of orthoses and 
assistive devices. 4th ed. St. Louis: Mosby; 2008.
Book with editors and edition
Luqmani R, Robb J, Porter D, Joseph B, editors. Textbook 
of orthopaedics, trauma and rheumatology. 2nd ed. St. 
Louis: Mosby; 2013.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: 
Underwood JCE, editor. General and systematic 
pathology. 4th ed. London: Churchill Livingstone; 2004, 
p. 615—72.
Book series with editors
Wilson JG, Fraser FC, editors. Handbook of teratology, 
vols.	1—4.	New	York:	Plenum	Press;	1977—1978.
Bulletin
World Health Organization. World health report 2002: 
Reducing risk, promoting healthy life. Geneva, 
Switzerland: World Health Organization; 2002.
Electronic publications
Duchin JS. Can preparedness for biological terrorism 
save us from pertussis? Arch Pediatr Adolesc Med 
2004;158(2). Available at http://archpedi.ama-assn.
org/cgi/content/full/158/2/106. Accessed June 12, 
2004.
Smeeth L, Iliffe S. Community screening for visual 
impairment in the elderly. Cochrane Database Syst Rev 
2002(2):CD001054. Doi:10.1002/14651858.CD1001054.
Thesis
Ayers AJ. Retention of resin restorations by means of 
enamel etching and by pins. MSD thesis, Indiana 
University, Indianapolis, 1971.
Website
American Association of Oral and Maxillofacial Surgeons. 
Wisdom teeth. Rosemont, IL: AAOMS, 2008. Available at 
http://www.aaoms.org/wisdom_teeth.php. Accessed 
November 15, 2008.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog	no.	49.	Rochester,	NY:	Eastman	Kodak;	1977,	p.	
2—3.
9.7. Tables
Tables should supplement, not duplicate, the text. 
They should have a concise table heading, be self-
explanatory, and numbered consecutively in the order 
of their citation in the text. Items requiring explanatory 
footnotes should be denoted using superscripted 
lowercase letters (a, b, c, etc.), with the footnotes 
arranged under the table in alphabetical order. 
Asterisks	(*,	**)	are	used	only	to	indicate	the	probability	
level of tests of significance. Abbreviations used in the 
table must be defined and placed after the footnotes 
in alphabetical order. If you include a block of data or 
table from another source, whether published or 
unpublished, you must acknowledge the original 
source.
9.8. Figures
9.8.1. General guidelines
The number of figures should be restricted to the 
minimum necessary to support the textual material. 
Figures should have an informative figure legend and be 
numbered in the order of their citation in the text. All 
symbols and abbreviations should be defined in the 
figure legend in alphabetical order. Items requiring 
explanatory footnotes should follow the same style as 
that for tables as described in Section 9.7.
Patient identification should be obscured. All 
lettering should be done professionally and should be in 
proportion to the drawing, graph or photograph. 
Photomicrographs must include an internal scale marker, 
and the legend should state the type of specimen, 
original magnification and stain.
Figures must be submitted as separate picture files, 
at the correct resolution (see Section 9.8.2.) and named 
according to the figure number and format, e.g., “Fig1.
tif”, “Fig2.jpg”.
9.8.2. Formats
Regardless of the application used, when your 
electronic artwork is finalized, please “save as” or 
convert the images to one of the following formats 
(note the resolution requirements for line drawings, 
halftones, and line/halftone combinations given 
below):
•	 EPS:	 vector	 drawings.	 Embed	 the	 font	 or	 save	 the	
text as “graphics”.
•	 TIFF:	 colour	 or	 greyscale	 photographs	 (halftones)—
use a minimum of 300 dpi.
•	 TIFF:	 bitmapped	 line	 drawings—use	 a	 minimum	 of	
1000 dpi.
•	 TIFF:	combination	of	bitmapped	line/halftone	(colour	
or greyscale)—use a minimum of 600 dpi.
•	 DOC,	XLS	or	PPT:	if	your	electronic	artwork	is	created	
in any of these Microsoft Office applications, please 
supply “as is”.
Please do not:
•	 Supply	 files	 that	 do	 not	 meet	 the	 resolution	
requirements detailed above;
•	 Supply	files	that	are	optimized	for	screen	use	(such	
as GIF, BMP, PICT, WPG) as the resolution is too low;
•	 Submit	graphics	that	are	disproportionately	large	for	
the content.
A detailed guide on electronic artwork is available 
at www.elsevier.com/artworkinstructions.
10. The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be 
acknowledged within 2 weeks of submission, and authors 
will be provided with a manuscript reference number 
for future correspondence. If such an acknowledgement 
is not received in a reasonable period of time, the 
author should contact the Editorial Office.
Submissions are reviewed by the Managing Editors to 
ensure that it contains all parts. Submissions will be 
rejected if the author has not supplied all the material 
and documents as outlined in these author instructions.
Manuscripts are then forwarded to the Editor-in-
Chief, who will determine whether the manuscript is 
classified as clinical or non-clinical. The manuscript is 
then assigned to the appropriate Section Editor for 
assessment. If the manuscript does not appear to be of 
sufficient merit or is not appropriate for the Journal, 
then the manuscript will be rejected without review. 
Rejected manuscripts will not be returned to authors 
unless requested.
Manuscripts that appear meritorious and 
appropriate for the Journal are reviewed by at least 
two Editorial Board members or expert consultants 
assigned by the Section Editors. The JOT follows a 
double-blind peer review process. Authors may submit 
a list in their cover letter of reviewers who they wish 
to review or not to review their manuscript. However, 
the actual peer reviewers invited will remain 
anonymous and may or may not be the reviewers 
suggested by the authors as the selection of reviewers 
is at the sole discretion of JOT Editors. The editors 
and reviewers will not disclose any information about 
a manuscript or its review to anyone except the 
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